EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Optimization of Lipid Nanoparticles with Robust Efficiency for the Delivery of Protein Therapeutics to Augment Cancer Immunotherapy

Lanfang Ren, Zeda Zhao, Yuqing Chao, Panting Yu, Zhoufang Mei, Bing Du iD, Yiyun Cheng iD

Advanced Science · 2025-05 · 12 (17)

DOI: 10.1002/advs.202500844 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 08.03.2025. Verfasst von Lanfang Ren und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East Ch…. Hauptthemen laut MEDLINE: Nanoparticles, Immunotherapy, Lipids, Drug Delivery Systems. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, Scientific Research Project funded by Shanghai Fifth People 's Hospital, Fudan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipid nanoparticles (LNPs) have been successful in delivering nucleic acids like siRNA and mRNA, but face challenges in protein delivery due to limited protein encapsulation and endosome escape. In this study, a family of LNPs is developed with robust high efficiency in addressing the multiple barriers in cytosolic protein delivery by incorporating clinically approved ionizable lipids into traditional cationic LNPs. The combination of cationic and ionizable lipids enables efficient protein binding and endosomal escape. Optimized LNPs efficiently deliver various proteins, including antibodies, enzymes, toxins, and Cas9 into living cells with reserved functions. Moreover, the designed LNPs show high serum stability during protein delivery, and the serum albumin adsorbed on LNPs facilitates protein delivery via albumin receptor‐mediated endocytosis, enabling highly efficient protein delivery in vivo. The optimized LNPs successfully deliver therapeutic proteins such as saporin and interleukin‐10 (IL‐10) to inhibit tumor growth in several animal models. The IL‐10 loaded LNPs enhanced the proliferation and cytotoxicity of T cells and improved the antitumor effect of adoptive transferred OT‐1 CD8 + T cells to melanoma. This study expands the applications of LNPs for the delivery of biomacromolecules, and the developed LNP formulations have enormous potential for the delivery of protein therapeutics to treat various diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesImmunotherapyLipidsDrug Delivery SystemsNeoplasmsAnimalsMiceHumansInterleukin-10SaporinsCell Line, TumorLiposomes

Stichwörter der Autor:innen

IL‐10cancer immunotherapylipid nanoparticlesprotein deliveryprotein therapeutics

Substanzen

LipidsLipid NanoparticlesInterleukin-10SaporinsLiposomes

Autor:innen und Institutionen

  • Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai, 200241, P. R. China.
  • Zhejiang Provincial Key Laboratory of Pancreatic Disease, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310006, P. R. China.
  • Department of Pulmonary and Critical Care Medicine, Center of Community-based Health Research, Shanghai Fifth People's Hospital, Fudan University, Shanghai, 200240, P. R. China.
  • Joint Center for Translational Medicine, Shanghai Fifth People's Hospital, Fudan University and School of Life Science, East China Normal University, Shanghai, 200240, P. R. China.

ORCID-Profile: Bing Du, Yiyun Cheng

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • Scientific Research Project funded by Shanghai Fifth People 's Hospital, Fudan University
  • Fundamental Research Funds for the Central Universities
  • National Key Research and Development Program of China

Zitieren

APA

Ren, L., Zhao, Z., Chao, Y., Yu, P., Mei, Z., Du, B., & Cheng, Y. (2025). Optimization of Lipid Nanoparticles with Robust Efficiency for the Delivery of Protein Therapeutics to Augment Cancer Immunotherapy. Advanced Science, 12(17). https://doi.org/10.1002/advs.202500844

Vancouver

Ren L, Zhao Z, Chao Y, Yu P, Mei Z, Du B, et al. Optimization of Lipid Nanoparticles with Robust Efficiency for the Delivery of Protein Therapeutics to Augment Cancer Immunotherapy. Advanced Science. 2025;12(17). doi:10.1002/advs.202500844

BibTeX
@article{Ren2025,
  author = {Ren, Lanfang and Zhao, Zeda and Chao, Yuqing and Yu, Panting and Mei, Zhoufang and Du, Bing and Cheng, Yiyun},
  title = {Optimization of Lipid Nanoparticles with Robust Efficiency for the Delivery of Protein Therapeutics to Augment Cancer Immunotherapy},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {17},
  doi = {10.1002/advs.202500844}
}
Kostenlos starten →